Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Stockholm - Delayed Quote SEK

Scandion Oncology A/S (SCOL.ST)

Compare
0.0090
-0.0004
(-4.26%)
At close: April 4 at 5:17:18 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
41,018
41,018
45,790
80,166
55,367
Operating Income
-41,018
-41,018
-45,790
-80,166
-55,367
Net Non Operating Interest Income Expense
333
333
94
-494
-767
Pretax Income
-40,912
-40,912
-44,704
-82,200
-57,213
Tax Provision
-4,254
-4,254
-5,500
-5,500
-5,508
Net Income Common Stockholders
-36,658
-36,658
-39,204
-76,700
-51,705
Diluted NI Available to Com Stockholders
-36,658
-36,658
-39,204
-76,700
-51,705
Basic EPS
-0.16
-0.16
-0.96
-0.57
-0.49
Diluted EPS
-0.16
-0.16
-0.96
-0.57
-0.49
Basic Average Shares
234,762.0760
234,762.0760
40,707
134,246.4890
105,980.4250
Diluted Average Shares
234,764.2150
234,764.2150
42,407
141,571.0630
110,927.2340
Total Operating Income as Reported
-41,148
-41,148
-45,357
-80,166
-55,367
Total Expenses
41,018
41,018
45,790
80,166
55,367
Net Income from Continuing & Discontinued Operation
-36,658
-36,658
-39,204
-76,700
-51,705
Normalized Income
-36,541.5173
-36,541.5173
-39,583.7274
-76,700
-51,705
Interest Income
338
338
132
1
--
Interest Expense
5
5
38
495
767
Net Interest Income
333
333
94
-494
-767
EBIT
-40,907
-40,907
-44,666
-81,705
-56,446
EBITDA
-40,462
-40,462
-43,697
-80,823
-55,842
Reconciled Depreciation
445
445
969
882
604
Net Income from Continuing Operation Net Minority Interest
-36,658
-36,658
-39,204
-76,700
-51,705
Total Unusual Items Excluding Goodwill
-130
-130
433
--
--
Total Unusual Items
-130
-130
433
--
--
Normalized EBITDA
-40,332
-40,332
-44,130
-80,823
-55,842
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
-13.5173
-13.5173
53.2726
--
--
12/31/2021 - 11/8/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

5KW.F SkinBioTherapeutics plc
0.2620
-6.43%
 
HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
 
2HA.MU Spero Therapeutics Inc
0.5750
-10.99%
 
HPHA.F Heidelberg Pharma AG
2.6500
-6.03%
 
22Z.SG Zealand Pharma A/S
58.30
-6.65%
 
05Y.F Vivoryon Therapeutics N.V.
1.7460
+0.92%
 
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
 
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
 
NP5.F Newron Pharmaceuticals S.p.A.
6.32
-10.99%
 
COMBI.ST CombiGene AB (publ)
2.3500
-1.26%